RALOXIFENE

RALOXIFENE was reported 14534 times

RALOXIFENE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CLEAR CELL CARCINOMA OF CERVIX 2 0.1538
1 GALLBLADDER FISTULA 2 0.0588
2 CARBUNCLE 14 0.0495
3 INSULINOMA 6 0.0339
4 WRIST DEFORMITY 20 0.0325
5 PERIPHLEBITIS 2 0.0270
6 SUBACUTE HEPATIC FAILURE 4 0.0268
7 COLONIC PSEUDO-OBSTRUCTION 7 0.0251
8 MONOCLONAL IMMUNOGLOBULIN PRESENT 14 0.0184
9 HYPOPHOSPHATASIA 2 0.0177
10 ENZYME LEVEL ABNORMAL 2 0.0143
11 CONGENITAL APLASIA 4 0.0129
12 BREAST HYPERPLASIA 4 0.0114
13 LARGE INTESTINE CARCINOMA 2 0.0108
14 VACCINATION SITE PAIN 6 0.0104
15 BONE FISSURE 4 0.0096
16 HYPOTHALAMO-PITUITARY DISORDER 14 0.0096
17 ALANINE AMINOTRANSFERASE 2 0.0090
18 ASPARTATE AMINOTRANSFERASE 2 0.0082
19 MALIGNANT CATATONIA 2 0.0076
20 MORAXELLA INFECTION 2 0.0073
21 RETINOPATHY HYPERTENSIVE 2 0.0066
22 COUNTERFEIT DRUG ADMINISTERED 2 0.0058
23 RETINAL VEIN THROMBOSIS 4 0.0057
24 FRACTURE NONUNION 7 0.0051
25 FIBROSIS 15 0.0049
26 INTESTINAL PSEUDO-OBSTRUCTION 4 0.0046
27 EYELID INFECTION 2 0.0045
28 PNEUMATOSIS 2 0.0045
29 BLOOD CHROMOGRANIN A INCREASED 2 0.0044
30 DYSLIPIDAEMIA 21 0.0041
31 OVERWEIGHT 22 0.0041
32 ARTERIOVENOUS FISTULA 2 0.0041
33 STERNAL FRACTURE 5 0.0041
34 FINGER DEFORMITY 19 0.0039
35 LIMB ASYMMETRY 3 0.0039
36 MILK-ALKALI SYNDROME 2 0.0038
37 BREAST CALCIFICATIONS 3 0.0038
38 PRESBYOPIA 2 0.0036
39 EUSTACHIAN TUBE DYSFUNCTION 2 0.0035
40 OPHTHALMIC HERPES SIMPLEX 2 0.0035
41 MYOPATHY TOXIC 2 0.0032
42 BLOOD ALKALINE PHOSPHATASE DECREASED 3 0.0032
43 OEDEMA GENITAL 2 0.0031
44 PERITONEAL DISORDER 2 0.0031
45 CATARACT NUCLEAR 2 0.0030
46 ARTHROSCOPY 2 0.0029
47 FOREARM FRACTURE 2 0.0029
48 INFUSION SITE INFLAMMATION 2 0.0028
49 DYSHIDROTIC ECZEMA 2 0.0028
50 GRANULOMA ANNULARE 2 0.0027
51 MYOCARDIAL INJURY 3 0.0027
52 CARBOHYDRATE ANTIGEN 15-3 INCREASED 2 0.0026
53 RETINAL PIGMENTATION 2 0.0025
54 FOOT DEFORMITY 28 0.0025
55 REFLUX GASTRITIS 3 0.0025
56 ATYPICAL FEMUR FRACTURE 7 0.0025
57 ENDOMETRIAL HYPERPLASIA 2 0.0025
58 FRACTURED SACRUM 3 0.0024
59 CEREBELLAR INFARCTION 4 0.0024
60 DEAFNESS TRANSITORY 2 0.0023
61 LACTOSE INTOLERANCE 6 0.0023
62 INFUSION SITE IRRITATION 3 0.0023
63 PURPURA 20 0.0023
64 UTERINE POLYP 4 0.0022
65 BODY HEIGHT DECREASED 22 0.0021
66 RENAL CYST 16 0.0020
67 NEPHROPATHY 18 0.0019
68 JOINT CONTRACTURE 2 0.0019
69 INFUSION SITE MASS 2 0.0018
70 INSTILLATION SITE REACTION 2 0.0018
71 GASTROINTESTINAL TRACT IRRITATION 2 0.0018
72 INFECTION SUSCEPTIBILITY INCREASED 4 0.0018
73 RESUSCITATION 3 0.0018
74 DRY AGE-RELATED MACULAR DEGENERATION 2 0.0018
75 RETINAL VEIN OCCLUSION 5 0.0017
76 LARGE INTESTINE PERFORATION 12 0.0017
77 MACULOPATHY 6 0.0017
78 INSTILLATION SITE IRRITATION 2 0.0017
79 HYPERAESTHESIA TEETH 2 0.0016
80 CALCIUM DEFICIENCY 2 0.0015
81 POSTMENOPAUSAL HAEMORRHAGE 4 0.0015
82 HEPATIC STEATOSIS 28 0.0015
83 OSTEONECROSIS OF JAW 37 0.0015
84 PRODUCT LABEL ISSUE 10 0.0015
85 POLYCYTHAEMIA 3 0.0015
86 RHEUMATOID NODULE 4 0.0015
87 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 2 0.0014
88 PELVIC VENOUS THROMBOSIS 2 0.0014
89 SEBORRHOEIC KERATOSIS 2 0.0014
90 FEMORAL NECK FRACTURE 7 0.0014
91 GALLBLADDER CANCER 2 0.0014
92 THORACIC VERTEBRAL FRACTURE 4 0.0014
93 NEPHRECTOMY 2 0.0013
94 ISCHAEMIC STROKE 24 0.0013
95 RETINOPATHY 5 0.0013
96 SPINAL COMPRESSION FRACTURE 11 0.0013
97 ASTIGMATISM 2 0.0013
98 LUMBAR VERTEBRAL FRACTURE 6 0.0013
99 NEOPLASM SKIN 2 0.0013
100 EYELIDS PRURITUS 4 0.0013
101 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
102 JOINT RANGE OF MOTION DECREASED 17 0.0013
103 INHIBITORY DRUG INTERACTION 2 0.0013
104 NASAL ULCER 2 0.0013
105 AORTIC VALVE DISEASE 2 0.0012
106 BREAST ENLARGEMENT 4 0.0012
107 COLONIC POLYP 2 0.0012
108 INSTILLATION SITE PAIN 3 0.0012
109 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
110 AORTIC ANEURYSM 9 0.0012
111 BLADDER NEOPLASM 2 0.0012
112 SYNOVITIS 21 0.0012
113 ACTINIC KERATOSIS 3 0.0012
114 RETINAL DISORDER 3 0.0012
115 INFUSION SITE DISCHARGE 2 0.0011
116 PAPULE 8 0.0011
117 KYPHOSIS 2 0.0011
118 POLYMYOSITIS 2 0.0011
119 MITRAL VALVE DISEASE 2 0.0011
120 SCIATICA 18 0.0011
121 BREAST SWELLING 3 0.0011
122 LARGE INTESTINAL ULCER 3 0.0011
123 LIP BLISTER 3 0.0011
124 RASH PUSTULAR 8 0.0011
125 OESOPHAGEAL SPASM 2 0.0011
126 HYPERTRICHOSIS 2 0.0011
127 LYMPH NODE PAIN 2 0.0011
128 COLITIS MICROSCOPIC 5 0.0011
129 BILE DUCT OBSTRUCTION 2 0.0011
130 OSTEOPOROTIC FRACTURE 2 0.0010
131 FIBULA FRACTURE 3 0.0010
132 GINGIVAL RECESSION 2 0.0010
133 PELVIC FRACTURE 8 0.0010
134 MIXED LIVER INJURY 3 0.0010
135 VITAMIN B12 DEFICIENCY 4 0.0010
136 DIVERTICULUM 7 0.0010
137 EYELID PAIN 2 0.0010
138 RENAL HAEMORRHAGE 2 0.0010
139 OSTEOLYSIS 2 0.0010
140 OSTEOPOROSIS 40 0.0010
141 INFUSION SITE PRURITUS 3 0.0009
142 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
143 RENAL NEOPLASM 2 0.0009
144 FOREIGN BODY SENSATION IN EYES 6 0.0009
145 VULVOVAGINAL DRYNESS 3 0.0009
146 JAW FRACTURE 2 0.0009
147 PERIODONTITIS 2 0.0009
148 INFUSION SITE HAEMORRHAGE 3 0.0009
149 ENDOMETRIAL CANCER 2 0.0009
150 CARBOHYDRATE ANTIGEN 125 INCREASED 3 0.0009
151 MENOPAUSAL SYMPTOMS 2 0.0009
152 ERYTHEMA MULTIFORME 8 0.0009
153 PULMONARY INFARCTION 2 0.0008
154 PLEURISY 5 0.0008
155 APPENDICECTOMY 3 0.0008
156 FACIAL BONES FRACTURE 3 0.0008
157 RADIUS FRACTURE 2 0.0008
158 BONE DENSITY DECREASED 26 0.0008
159 CHOLELITHIASIS 27 0.0008
160 LIMB INJURY 22 0.0008
161 HYPERPARATHYROIDISM SECONDARY 2 0.0008
162 PATHOLOGICAL FRACTURE 4 0.0008
163 PHOTOSENSITIVITY REACTION 13 0.0008
164 DRUG DELIVERY SYSTEM MALFUNCTION 4 0.0008
165 MOVEMENT DISORDER 25 0.0008
166 DRUG TITRATION ERROR 2 0.0008
167 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6 0.0008
168 HYPERSENSITIVITY VASCULITIS 2 0.0008
169 PNEUMONIA FUNGAL 3 0.0008
170 CEREBRAL ATROPHY 3 0.0008
171 CARDIAC FAILURE ACUTE 5 0.0007
172 CARDIOMYOPATHY 11 0.0007
173 FEMUR FRACTURE 23 0.0007
174 CLONUS 2 0.0007
175 ORAL FUNGAL INFECTION 2 0.0007
176 ECCHYMOSIS 5 0.0007
177 ACUTE CORONARY SYNDROME 6 0.0007
178 HAIR GROWTH ABNORMAL 5 0.0007
179 RASH MORBILLIFORM 2 0.0007
180 DYSSTASIA 21 0.0007
181 LUNG CONSOLIDATION 2 0.0007
182 NECK MASS 2 0.0007
183 CEREBRAL THROMBOSIS 2 0.0007
184 FEBRILE BONE MARROW APLASIA 3 0.0007
185 UTERINE HAEMORRHAGE 3 0.0007
186 CARDIAC VALVE DISEASE 4 0.0007
187 LIP PAIN 2 0.0007
188 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
189 STRESS CARDIOMYOPATHY 4 0.0007
190 URINE OUTPUT DECREASED 6 0.0007
191 DIVERTICULUM INTESTINAL 3 0.0007
192 CREPITATIONS 2 0.0007
193 METABOLIC ENCEPHALOPATHY 2 0.0007
194 IRITIS 2 0.0007
195 JOINT STIFFNESS 17 0.0006
196 INFUSION SITE EXTRAVASATION 4 0.0006
197 BLOOD BLISTER 2 0.0006
198 SWELLING OF EYELID 4 0.0006
199 OSTEOARTHRITIS 27 0.0006
200 BLOOD PROLACTIN INCREASED 3 0.0006
201 SEASONAL ALLERGY 9 0.0006
202 FOREIGN BODY IN THROAT 2 0.0006
203 FRACTURE 12 0.0006
204 BREAST CANCER RECURRENT 2 0.0006
205 DIZZINESS POSTURAL 6 0.0006
206 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
207 FLUID INTAKE REDUCED 3 0.0006
208 SKIN DISORDER 20 0.0006
209 MENINGITIS 4 0.0006
210 MACULAR DEGENERATION 7 0.0006
211 RIB FRACTURE 12 0.0006
212 MUSCLE STRAIN 5 0.0006
213 PHARYNGOLARYNGEAL PAIN 3 0.0006
214 GINGIVITIS 3 0.0006
215 ANAL INCONTINENCE 5 0.0006
216 BONE LESION 2 0.0006
217 CHEILITIS 3 0.0006
218 OSTEOMYELITIS 10 0.0006
219 SCLERODERMA 2 0.0005
220 SPINAL FRACTURE 11 0.0005
221 JAW DISORDER 3 0.0005
222 FAECALOMA 3 0.0005
223 FLATULENCE 31 0.0005
224 FOOD INTOLERANCE 2 0.0005
225 RECTAL DISCHARGE 2 0.0005
226 PSORIATIC ARTHROPATHY 22 0.0005
227 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
228 NERVE COMPRESSION 5 0.0005
229 IMPULSIVE BEHAVIOUR 2 0.0005
230 CHRONIC SINUSITIS 2 0.0005
231 BREAST TENDERNESS 4 0.0005
232 COLECTOMY 3 0.0005
233 HEPATIC NECROSIS 2 0.0005
234 OSTEOPENIA 8 0.0005
235 TROPONIN INCREASED 4 0.0005
236 NEUROLOGICAL SYMPTOM 3 0.0005
237 CONCUSSION 4 0.0005
238 RASH MACULAR 18 0.0005
239 RHINOVIRUS INFECTION 2 0.0005
240 ORAL INFECTION 2 0.0005
241 BACTERAEMIA 6 0.0005
242 UTERINE CANCER 4 0.0005
243 MUSCULOSKELETAL PAIN 26 0.0005
244 LIVER DISORDER 22 0.0005
245 ARTHRITIS 39 0.0005
246 HEPATOCELLULAR INJURY 7 0.0005
247 MENISCUS INJURY 3 0.0005
248 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
249 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2 0.0005
250 VENTRICULAR EXTRASYSTOLES 5 0.0005
251 INFUSION SITE SWELLING 3 0.0005
252 HALLUCINATIONS, MIXED 2 0.0005
253 INFUSION SITE ERYTHEMA 4 0.0005
254 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
255 HIP FRACTURE 15 0.0005
256 INFUSION SITE PAIN 6 0.0005
257 BREAST CANCER METASTATIC 5 0.0005
258 HORDEOLUM 2 0.0005
259 CHAPPED LIPS 2 0.0005
260 MONOPLEGIA 2 0.0005
261 TENDON DISORDER 3 0.0005
262 NAIL DISORDER 4 0.0005
263 MELANOCYTIC NAEVUS 2 0.0005
264 ONYCHOMYCOSIS 2 0.0005
265 GROIN PAIN 4 0.0005
266 SPINAL OSTEOARTHRITIS 4 0.0005
267 THYROID DISORDER 7 0.0005
268 INTENTIONAL DEVICE MISUSE 2 0.0005
269 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
270 PHYSICAL DISABILITY 2 0.0005
271 FACIAL PAIN 4 0.0004
272 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
273 OCULAR DISCOMFORT 5 0.0004
274 PNEUMOTHORAX 7 0.0004
275 IMPAIRED DRIVING ABILITY 5 0.0004
276 EAR DISORDER 2 0.0004
277 ONYCHOCLASIS 3 0.0004
278 ISCHAEMIA 2 0.0004
279 DROOLING 3 0.0004
280 EYE OPERATION 2 0.0004
281 LARGE INTESTINE POLYP 3 0.0004
282 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
283 LOCALISED OEDEMA 2 0.0004
284 NEPHROGENIC ANAEMIA 2 0.0004
285 EYELID OEDEMA 5 0.0004
286 EXTRASYSTOLES 3 0.0004
287 DEMENTIA 12 0.0004
288 DEFAECATION URGENCY 3 0.0004
289 SKIN ABRASION 2 0.0004
290 HYPOCALCAEMIA 8 0.0004
291 ATAXIA 5 0.0004
292 DISEASE RECURRENCE 20 0.0004
293 WRIST FRACTURE 5 0.0004
294 ARTHROPATHY 23 0.0004
295 INCORRECT DOSAGE ADMINISTERED 2 0.0004
296 EYE PAIN 23 0.0004
297 MUSCULOSKELETAL DISCOMFORT 7 0.0004
298 KNEE OPERATION 4 0.0004
299 CARDIOMEGALY 5 0.0004
300 LIGAMENT SPRAIN 4 0.0004
301 FOOT OPERATION 2 0.0004
302 DIABETIC NEUROPATHY 2 0.0004
303 SUNBURN 3 0.0004
304 ANEURYSM 2 0.0004
305 HYPERNATRAEMIA 2 0.0004
306 HOT FLUSH 30 0.0004
307 HEPATOCELLULAR CARCINOMA 3 0.0004
308 PROCEDURAL COMPLICATION 3 0.0004
309 PHLEBITIS 2 0.0004
310 PERIPHERAL VASCULAR DISORDER 2 0.0004
311 HIATUS HERNIA 5 0.0004
312 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
313 BACK PAIN 89 0.0004
314 MALABSORPTION 2 0.0004
315 BRAIN FOG 6 0.0004
316 WEIGHT FLUCTUATION 4 0.0004
317 PRODUCT USE COMPLAINT 6 0.0004
318 ATRIAL FIBRILLATION 37 0.0004
319 OCULAR HYPERAEMIA 18 0.0004
320 SERUM FERRITIN INCREASED 2 0.0004
321 INCONTINENCE 4 0.0004
322 BLOOD ALBUMIN DECREASED 3 0.0004
323 RESPIRATORY TRACT CONGESTION 6 0.0004
324 ATRIAL FLUTTER 3 0.0004
325 NECK PAIN 21 0.0004
326 RETCHING 8 0.0004
327 BLOOD PRESSURE FLUCTUATION 9 0.0004
328 SENSORY DISTURBANCE 6 0.0004
329 HAIR TEXTURE ABNORMAL 5 0.0004
330 RHINITIS 3 0.0004
331 PRODUCT RESIDUE PRESENT 2 0.0004
332 ERYTHEMA OF EYELID 2 0.0004
333 BACK INJURY 4 0.0004
334 OESOPHAGITIS 4 0.0004
335 WOUND INFECTION 4 0.0004
336 PULMONARY FIBROSIS 7 0.0004
337 SEROTONIN SYNDROME 7 0.0004
338 HAIR DISORDER 3 0.0004
339 HYPERKERATOSIS 2 0.0004
340 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
341 HEMIPLEGIA 3 0.0004
342 TOOTH DISORDER 8 0.0004
343 APHONIA 5 0.0004
344 MACULAR OEDEMA 2 0.0004
345 ANGIOPATHY 2 0.0004
346 SNEEZING 8 0.0004
347 BLOOD CALCIUM DECREASED 4 0.0004
348 BLINDNESS UNILATERAL 5 0.0004
349 EYE INFECTION 4 0.0004
350 MUSCULOSKELETAL STIFFNESS 31 0.0004
351 DRUG-INDUCED LIVER INJURY 11 0.0004
352 HYPERTONIA 2 0.0003
353 FALL 116 0.0003
354 BLOOD MAGNESIUM DECREASED 3 0.0003
355 PSYCHOLOGICAL TRAUMA 3 0.0003
356 EXERCISE TOLERANCE DECREASED 2 0.0003
357 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
358 MYOPATHY 3 0.0003
359 HERPES VIRUS INFECTION 2 0.0003
360 TASTE DISORDER 7 0.0003
361 RALES 2 0.0003
362 CATARACT OPERATION 2 0.0003
363 CATARACT 20 0.0003
364 BALANCE DISORDER 29 0.0003
365 ACCIDENT 4 0.0003
366 DRY MOUTH 27 0.0003
367 APHASIA 10 0.0003
368 EYE IRRITATION 19 0.0003
369 BURSITIS 4 0.0003
370 EXOSTOSIS 3 0.0003
371 CEREBRAL INFARCTION 8 0.0003
372 INCREASED TENDENCY TO BRUISE 3 0.0003
373 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
374 HYPERCALCAEMIA 4 0.0003
375 MUSCULOSKELETAL CHEST PAIN 5 0.0003
376 CHOLANGITIS 2 0.0003
377 CYST 4 0.0003
378 PSORIASIS 42 0.0003
379 NASAL DRYNESS 2 0.0003
380 LACERATION 3 0.0003
381 SPINAL DISORDER 3 0.0003
382 FOOT FRACTURE 6 0.0003
383 SPUTUM DISCOLOURED 3 0.0003
384 MUSCLE SPASMS 58 0.0003
385 PRODUCT PACKAGING ISSUE 3 0.0003
386 RASH PRURITIC 17 0.0003
387 HYPOPHAGIA 8 0.0003
388 LOWER LIMB FRACTURE 6 0.0003
389 PERIPHERAL SWELLING 48 0.0003
390 HAEMOGLOBIN ABNORMAL 2 0.0003
391 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
392 HYPERCHOLESTEROLAEMIA 3 0.0003
393 NIGHT SWEATS 10 0.0003
394 ERUCTATION 6 0.0003
395 SKIN ULCER 8 0.0003
396 BREAST CANCER STAGE III 2 0.0003
397 HEPATIC ENZYME INCREASED 21 0.0003
398 AUTOIMMUNE DISORDER 3 0.0003
399 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
400 VITAMIN D DEFICIENCY 3 0.0003
401 HAEMORRHOIDS 6 0.0003
402 BACK DISORDER 5 0.0003
403 RESPIRATORY TRACT INFECTION 8 0.0003
404 PLATELET COUNT INCREASED 4 0.0003
405 COELIAC DISEASE 3 0.0003
406 PULMONARY EMBOLISM 29 0.0003
407 DYSPEPSIA 30 0.0003
408 DYSGRAPHIA 2 0.0003
409 PRODUCT FORMULATION ISSUE 2 0.0003
410 GAIT DISTURBANCE 58 0.0003
411 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
412 SINUS DISORDER 6 0.0003
413 BLISTER 17 0.0003
414 BLADDER DISORDER 3 0.0003
415 SKIN MASS 2 0.0003
416 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
417 VISION BLURRED 41 0.0003
418 MALIGNANT MELANOMA 4 0.0003
419 FULL BLOOD COUNT DECREASED 6 0.0003
420 BRONCHIECTASIS 2 0.0003
421 COLITIS ISCHAEMIC 2 0.0003
422 METASTASES TO LYMPH NODES 2 0.0003
423 HEMIPARESIS 5 0.0003
424 MOOD ALTERED 8 0.0003
425 EAR DISCOMFORT 3 0.0003
426 HELICOBACTER INFECTION 3 0.0003
427 INFLAMMATION 15 0.0003
428 BONE PAIN 17 0.0003
429 JOINT EFFUSION 2 0.0003
430 POOR VENOUS ACCESS 3 0.0003
431 DIVERTICULITIS 8 0.0003
432 PROCEDURAL PAIN 8 0.0003
433 AUTOIMMUNE HEPATITIS 2 0.0003
434 PRODUCT ODOUR ABNORMAL 3 0.0003
435 SCRATCH 3 0.0003
436 DEVICE OCCLUSION 4 0.0003
437 ARTHRALGIA 118 0.0003
438 JOINT DISLOCATION 3 0.0003
439 PULMONARY TOXICITY 2 0.0003
440 HAND FRACTURE 2 0.0003
441 DRUG ERUPTION 5 0.0003
442 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
443 JOINT INJURY 6 0.0003
444 DRY EYE 14 0.0003
445 PNEUMONIA ASPIRATION 7 0.0003
446 THIRST 5 0.0003
447 POOR QUALITY SLEEP 6 0.0003
448 RHINORRHOEA 18 0.0003
449 CELLULITIS 14 0.0003
450 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
451 AMNESIA 18 0.0003
452 DIABETES MELLITUS 21 0.0003
453 RESTLESS LEGS SYNDROME 5 0.0003
454 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
455 BONE DISORDER 5 0.0003
456 ORAL DISORDER 2 0.0003
457 GASTROINTESTINAL PAIN 3 0.0003
458 BLINDNESS TRANSIENT 2 0.0003
459 DENTAL CARIES 3 0.0003
460 CEREBRAL DISORDER 2 0.0003
461 LIP SWELLING 9 0.0003
462 CONTUSION 26 0.0003
463 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
464 THINKING ABNORMAL 5 0.0003
465 INTESTINAL PERFORATION 3 0.0003
466 BLOOD POTASSIUM DECREASED 8 0.0003
467 REBOUND EFFECT 3 0.0003
468 INTESTINAL OBSTRUCTION 10 0.0003
469 MITRAL VALVE INCOMPETENCE 3 0.0003
470 SINUSITIS 27 0.0003
471 HAEMATURIA 9 0.0003
472 DEVICE FAILURE 4 0.0003
473 MUSCULOSKELETAL DISORDER 5 0.0003
474 HAEMODYNAMIC INSTABILITY 2 0.0003
475 HIP ARTHROPLASTY 4 0.0003
476 HERPES ZOSTER 15 0.0003
477 RENAL FAILURE CHRONIC 2 0.0003
478 GLAUCOMA 5 0.0003
479 LYMPHOMA 4 0.0003
480 PAIN IN EXTREMITY 76 0.0003
481 APHTHOUS ULCER 2 0.0003
482 BREAST CANCER 24 0.0003
483 COVID-19 45 0.0003
484 DYSPHONIA 15 0.0003
485 SWOLLEN TONGUE 8 0.0003
486 SLEEP DISORDER 18 0.0003
487 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
488 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
489 BLOOD DISORDER 2 0.0002
490 CARDIAC FAILURE 20 0.0002
491 SENSORY LOSS 2 0.0002
492 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
493 MYASTHENIA GRAVIS 2 0.0002
494 FRUSTRATION TOLERANCE DECREASED 2 0.0002
495 NOCTURIA 3 0.0002
496 MUSCLE DISORDER 2 0.0002
497 FIBROMYALGIA 6 0.0002
498 BODY TEMPERATURE INCREASED 5 0.0002
499 ASPHYXIA 2 0.0002
500 URTICARIA 41 0.0002
501 FEELING HOT 15 0.0002
502 HYPERSOMNIA 7 0.0002
503 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
504 HICCUPS 2 0.0002
505 IMPAIRED HEALING 8 0.0002
506 SPINAL OPERATION 3 0.0002
507 EYE DISORDER 8 0.0002
508 PRODUCT SUBSTITUTION ISSUE 14 0.0002
509 NEUROPATHY PERIPHERAL 23 0.0002
510 URINARY RETENTION 8 0.0002
511 GAIT INABILITY 8 0.0002
512 CHRONIC KIDNEY DISEASE 18 0.0002
513 URINARY INCONTINENCE 7 0.0002
514 INJECTION SITE IRRITATION 3 0.0002
515 URINARY TRACT INFECTION 40 0.0002
516 THERAPY CESSATION 12 0.0002
517 SCAR 4 0.0002
518 JOINT SWELLING 28 0.0002
519 RASH GENERALISED 6 0.0002
520 CARDIAC MURMUR 2 0.0002
521 STOMATITIS 14 0.0002
522 PLEURAL EFFUSION 14 0.0002
523 ORTHOSTATIC HYPOTENSION 4 0.0002
524 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
525 DEAFNESS 6 0.0002
526 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
527 MUSCULAR WEAKNESS 26 0.0002
528 DEVICE USE ISSUE 4 0.0002
529 COUGH 64 0.0002
530 BLOOD CALCIUM INCREASED 2 0.0002
531 GASTRITIS 6 0.0002
532 DISORIENTATION 9 0.0002
533 IMMUNOSUPPRESSION 2 0.0002
534 PRODUCT COMMUNICATION ISSUE 2 0.0002
535 PRURITUS 87 0.0002
536 DYSMENORRHOEA 3 0.0002
537 RENAL FAILURE 30 0.0002
538 CONSTIPATION 49 0.0002
539 SWELLING 21 0.0002
540 THROMBOSIS 18 0.0002
541 MYOSITIS 2 0.0002
542 MOBILITY DECREASED 16 0.0002
543 HEART RATE IRREGULAR 5 0.0002
544 UVEITIS 3 0.0002
545 INFLUENZA LIKE ILLNESS 18 0.0002
546 NEPHROLITHIASIS 10 0.0002
547 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
548 HYPERTENSION 46 0.0002
549 IRON DEFICIENCY ANAEMIA 2 0.0002
550 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
551 POLLAKIURIA 9 0.0002
552 HYPOMAGNESAEMIA 3 0.0002
553 HUNGER 3 0.0002
554 CARDIO-RESPIRATORY ARREST 9 0.0002
555 ROAD TRAFFIC ACCIDENT 9 0.0002
556 HAEMOPTYSIS 6 0.0002
557 EYE SWELLING 8 0.0002
558 SWELLING FACE 14 0.0002
559 MASS 3 0.0002
560 WOUND 6 0.0002
561 ABDOMINAL DISCOMFORT 36 0.0002
562 HEPATIC ENCEPHALOPATHY 2 0.0002
563 OSTEONECROSIS 7 0.0002
564 PHOTOPHOBIA 4 0.0002
565 DYSPNOEA EXERTIONAL 8 0.0002
566 LEUKAEMIA 2 0.0002
567 PAIN IN JAW 6 0.0002
568 ARRHYTHMIA 10 0.0002
569 FUNGAL INFECTION 7 0.0002
570 EYE INFLAMMATION 2 0.0002
571 PARALYSIS 3 0.0002
572 PRODUCTIVE COUGH 10 0.0002
573 ANGINA PECTORIS 6 0.0002
574 CHOLESTASIS 4 0.0002
575 ATELECTASIS 2 0.0002
576 PRESCRIBED OVERDOSE 4 0.0002
577 HYPOKINESIA 3 0.0002
578 INFLUENZA 23 0.0002
579 EAR PAIN 4 0.0002
580 OROPHARYNGEAL PAIN 19 0.0002
581 CHEST PAIN 38 0.0002
582 CHOKING 4 0.0002
583 ORAL HERPES 4 0.0002
584 ASCITES 6 0.0002
585 DRUG INTERACTION 32 0.0002
586 SKIN EXFOLIATION 17 0.0002
587 COLON CANCER 3 0.0002
588 IMMUNODEFICIENCY 3 0.0002
589 UPPER LIMB FRACTURE 4 0.0002
590 THROAT IRRITATION 9 0.0002
591 PRESCRIBED UNDERDOSE 4 0.0002
592 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
593 FATIGUE 156 0.0002
594 MYALGIA 34 0.0002
595 BURNING SENSATION 14 0.0002
596 BONE LOSS 3 0.0002
597 INSOMNIA 53 0.0002
598 HYPOXIA 7 0.0002
599 PRODUCT PHYSICAL ISSUE 4 0.0002
600 EMPHYSEMA 2 0.0002
601 PARAESTHESIA 31 0.0002
602 VERTIGO 12 0.0002
603 ASTHENIA 74 0.0002
604 DRY THROAT 2 0.0002
605 FLUSHING 20 0.0002
606 FLUID RETENTION 10 0.0002
607 TINNITUS 9 0.0002
608 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
609 ERYTHEMA 40 0.0002
610 PERITONITIS 4 0.0002
611 TOOTH LOSS 4 0.0002
612 DIPLOPIA 5 0.0002
613 BASAL CELL CARCINOMA 3 0.0002
614 DERMATITIS 4 0.0002
615 DIZZINESS 95 0.0002
616 KNEE ARTHROPLASTY 4 0.0002
617 MOUTH ULCERATION 4 0.0002
618 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
619 HEAD INJURY 6 0.0002
620 HALLUCINATION, VISUAL 4 0.0002
621 FULL BLOOD COUNT ABNORMAL 2 0.0002
622 RENAL PAIN 2 0.0002
623 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
624 HYPOTHYROIDISM 6 0.0002
625 BREAST PAIN 2 0.0002
626 HYPERHIDROSIS 24 0.0002
627 SKIN CANCER 4 0.0002
628 DECREASED ACTIVITY 2 0.0002
629 PRURITUS GENERALISED 4 0.0002
630 BIPOLAR DISORDER 2 0.0002
631 SKIN LACERATION 2 0.0002
632 BLOOD PRESSURE INCREASED 28 0.0002
633 MULTIPLE FRACTURES 3 0.0002
634 MANIA 3 0.0002
635 SKIN LESION 5 0.0002
636 VIRAL INFECTION 6 0.0002
637 DISCOMFORT 11 0.0002
638 COAGULOPATHY 3 0.0002
639 BLOOD UREA INCREASED 3 0.0002
640 WEIGHT DECREASED 50 0.0002
641 MALNUTRITION 2 0.0002
642 GLOSSODYNIA 4 0.0002
643 PULMONARY OEDEMA 8 0.0002
644 EYE PRURITUS 6 0.0002
645 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
646 DIARRHOEA 115 0.0002
647 OXYGEN SATURATION DECREASED 10 0.0002
648 FACE OEDEMA 3 0.0002
649 CANDIDA INFECTION 3 0.0002
650 DECREASED APPETITE 41 0.0002
651 RHEUMATOID ARTHRITIS 20 0.0002
652 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
653 PRODUCT AVAILABILITY ISSUE 4 0.0002
654 BRONCHITIS 13 0.0002
655 DERMATITIS CONTACT 2 0.0002
656 SCAB 2 0.0002
657 DYSGEUSIA 13 0.0002
658 RED BLOOD CELL COUNT DECREASED 5 0.0002
659 NEOPLASM 2 0.0002
660 CONFUSIONAL STATE 28 0.0002
661 METASTASES TO LUNG 2 0.0002
662 PERICARDIAL EFFUSION 4 0.0002
663 DYSKINESIA 7 0.0002
664 INTENTIONAL PRODUCT MISUSE 15 0.0002
665 COLD SWEAT 3 0.0002
666 HEAD DISCOMFORT 3 0.0002
667 HEADACHE 106 0.0002
668 PRODUCT DOSE OMISSION 11 0.0002
669 GALLBLADDER DISORDER 3 0.0002
670 PNEUMONIA 54 0.0002
671 BLOOD GLUCOSE DECREASED 8 0.0002
672 CHEST DISCOMFORT 17 0.0002
673 BLOOD PRESSURE DECREASED 11 0.0002
674 LACRIMATION INCREASED 5 0.0002
675 PELVIC PAIN 3 0.0002
676 CORONARY ARTERY DISEASE 5 0.0002
677 MENTAL IMPAIRMENT 4 0.0002
678 ADRENAL INSUFFICIENCY 2 0.0002
679 END STAGE RENAL DISEASE 3 0.0002
680 SOMNOLENCE 33 0.0002
681 ALOPECIA 32 0.0002
682 ANAEMIA 31 0.0002
683 INJECTION SITE MASS 6 0.0002
684 ILEUS 2 0.0002
685 HEPATIC FUNCTION ABNORMAL 6 0.0002
686 MEMORY IMPAIRMENT 22 0.0002
687 PLATELET COUNT DECREASED 17 0.0002
688 DYSARTHRIA 6 0.0002
689 HALLUCINATION 12 0.0002
690 RASH 69 0.0002
691 MUSCLE ATROPHY 2 0.0002
692 GASTRIC ULCER 3 0.0002
693 NASOPHARYNGITIS 29 0.0002
694 CYSTITIS 5 0.0002
695 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
696 DRUG PRESCRIBING ERROR 3 0.0002
697 MYDRIASIS 2 0.0002
698 ROTATOR CUFF SYNDROME 2 0.0002
699 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
700 DYSPNOEA 88 0.0002
701 ANOREXIA 2 0.0002
702 HERNIA 3 0.0002
703 ANAPHYLACTIC SHOCK 4 0.0002
704 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
705 EXPOSURE VIA SKIN CONTACT 4 0.0002
706 DEEP VEIN THROMBOSIS 10 0.0002
707 NODULE 2 0.0002
708 ECZEMA 8 0.0002
709 BEDRIDDEN 2 0.0002
710 IMMUNE SYSTEM DISORDER 2 0.0002
711 PULMONARY CONGESTION 2 0.0002
712 HYPOKALAEMIA 7 0.0002
713 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
714 BLOOD PRESSURE ABNORMAL 3 0.0002
715 HYPERSENSITIVITY 28 0.0002
716 UNDERDOSE 11 0.0002
717 EXPIRED PRODUCT ADMINISTERED 5 0.0002
718 PAIN 92 0.0001
719 PAIN OF SKIN 4 0.0001
720 PRODUCT ADMINISTRATION ERROR 3 0.0001
721 EXTRA DOSE ADMINISTERED 6 0.0001
722 SINUS CONGESTION 2 0.0001
723 FEEDING DISORDER 3 0.0001
724 THROAT TIGHTNESS 4 0.0001
725 NAUSEA 117 0.0001
726 OEDEMA PERIPHERAL 18 0.0001
727 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
728 DYSPHAGIA 14 0.0001
729 NEUTROPHIL COUNT DECREASED 6 0.0001
730 GINGIVAL BLEEDING 2 0.0001
731 ABDOMINAL PAIN 34 0.0001
732 HAEMOGLOBIN DECREASED 15 0.0001
733 FEELING ABNORMAL 35 0.0001
734 INTERSTITIAL LUNG DISEASE 7 0.0001
735 INCORRECT DOSE ADMINISTERED 33 0.0001
736 NIGHTMARE 5 0.0001
737 ORAL DISCOMFORT 2 0.0001
738 ABDOMINAL DISTENSION 15 0.0001
739 FEELING COLD 4 0.0001
740 WEIGHT INCREASED 32 0.0001
741 LYMPHOPENIA 2 0.0001
742 HEART RATE INCREASED 14 0.0001
743 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
744 EATING DISORDER 3 0.0001
745 INTENTIONAL DOSE OMISSION 4 0.0001
746 BRONCHOSPASM 2 0.0001
747 IRRITABLE BOWEL SYNDROME 3 0.0001
748 RECTAL HAEMORRHAGE 6 0.0001
749 HYPOACUSIS 6 0.0001
750 MYELODYSPLASTIC SYNDROME 2 0.0001
751 HYPERTHYROIDISM 2 0.0001
752 BLOOD CREATININE INCREASED 9 0.0001
753 PRODUCT DISPENSING ERROR 3 0.0001
754 GASTROENTERITIS 2 0.0001
755 ACCIDENTAL OVERDOSE 5 0.0001
756 RESTLESSNESS 5 0.0001
757 MIGRAINE 13 0.0001
758 NASAL CONGESTION 8 0.0001
759 ABDOMINAL PAIN UPPER 28 0.0001
760 DYSURIA 5 0.0001
761 FEBRILE NEUTROPENIA 9 0.0001
762 ACUTE MYOCARDIAL INFARCTION 4 0.0001
763 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
764 STEVENS-JOHNSON SYNDROME 3 0.0001
765 TRANSAMINASES INCREASED 3 0.0001
766 PULMONARY MASS 2 0.0001
767 GASTROINTESTINAL DISORDER 12 0.0001
768 RESPIRATORY DISORDER 4 0.0001
769 ADVERSE DRUG REACTION 12 0.0001
770 PRODUCT USE ISSUE 25 0.0001
771 DERMATITIS ATOPIC 7 0.0001
772 HYPOAESTHESIA ORAL 2 0.0001
773 PRODUCT DOSE OMISSION ISSUE 39 0.0001
774 MALAISE 58 0.0001
775 BLOOD COUNT ABNORMAL 2 0.0001
776 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
777 CONDITION AGGRAVATED 40 0.0001
778 INFECTION 19 0.0001
779 DRUG DISPENSING ERROR 2 0.0001
780 INSURANCE ISSUE 2 0.0001
781 PHARYNGEAL OEDEMA 2 0.0001
782 LIMB DISCOMFORT 4 0.0001
783 ANKLE FRACTURE 2 0.0001
784 VISUAL IMPAIRMENT 16 0.0001
785 DELUSION 2 0.0001
786 COGNITIVE DISORDER 6 0.0001
787 ACUTE MYELOID LEUKAEMIA 2 0.0001
788 PLASMA CELL MYELOMA 5 0.0001
789 MENINGIOMA 2 0.0001
790 PALPITATIONS 15 0.0001
791 DEVICE MALFUNCTION 9 0.0001
792 CHILLS 15 0.0001
793 TREATMENT NONCOMPLIANCE 7 0.0001
794 DRUG DOSE OMISSION 21 0.0001
795 HAEMATOCHEZIA 7 0.0001
796 TREMOR 21 0.0001
797 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
798 ILLNESS 13 0.0001
799 THERAPY INTERRUPTED 9 0.0001
800 OBESITY 2 0.0001
801 VOMITING 59 0.0001
802 ABSCESS 2 0.0001
803 HYPONATRAEMIA 7 0.0001
804 ASTHMA 14 0.0001
805 TACHYCARDIA 11 0.0001
806 RESPIRATORY FAILURE 9 0.0001
807 BLOOD POTASSIUM INCREASED 2 0.0001
808 BLINDNESS 5 0.0001
809 INJECTION SITE URTICARIA 3 0.0001
810 METASTASES TO BONE 2 0.0001
811 STAPHYLOCOCCAL INFECTION 4 0.0001
812 INFUSION RELATED REACTION 8 0.0001
813 VISUAL ACUITY REDUCED 4 0.0001
814 AGEUSIA 3 0.0001
815 LEUKOPENIA 6 0.0001
816 DRY SKIN 16 0.0001
817 NEOPLASM MALIGNANT 8 0.0001
818 RENAL IMPAIRMENT 10 0.0001
819 GASTRIC DISORDER 4 0.0001
820 SEPSIS 13 0.0001
821 ANXIETY 33 0.0001
822 HAEMATOMA 3 0.0001
823 SPEECH DISORDER 6 0.0001
824 INJECTION SITE PAIN 35 0.0001
825 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
826 DEPRESSED MOOD 6 0.0001
827 BRADYCARDIA 6 0.0001
828 OFF LABEL USE 99 0.0001
829 LYMPHADENOPATHY 4 0.0001
830 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
831 INJECTION SITE ERYTHEMA 14 0.0001
832 SEIZURE 13 0.0001
833 CEREBRAL HAEMORRHAGE 4 0.0001
834 FEAR 3 0.0001
835 BLOOD BILIRUBIN INCREASED 3 0.0001
836 GASTROENTERITIS VIRAL 2 0.0001
837 CRYING 4 0.0001
838 LOSS OF CONSCIOUSNESS 14 0.0001
839 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
840 SKIN DISCOLOURATION 5 0.0001
841 RESPIRATORY DISTRESS 3 0.0001
842 CONJUNCTIVITIS 2 0.0001
843 MIDDLE INSOMNIA 2 0.0001
844 EPISTAXIS 8 0.0001
845 HYPOAESTHESIA 16 0.0001
846 CARDIAC DISORDER 10 0.0001
847 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
848 HEPATIC CIRRHOSIS 2 0.0001
849 COLITIS 4 0.0001
850 DEHYDRATION 14 0.0001
851 FEELING JITTERY 2 0.0001
852 RASH ERYTHEMATOUS 5 0.0001
853 ACUTE KIDNEY INJURY 16 0.0001
854 NEEDLE ISSUE 3 0.0001
855 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
856 SKIN FISSURES 2 0.0001
857 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
858 LUNG DISORDER 5 0.0001
859 DISABILITY 2 0.0001
860 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
861 RENAL INJURY 3 0.0001
862 HAEMATOCRIT DECREASED 2 0.0001
863 INJECTION SITE BRUISING 8 0.0001
864 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
865 BONE MARROW FAILURE 2 0.0001
866 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
867 MYOCARDIAL INFARCTION 17 0.0001
868 PRODUCT PREPARATION ERROR 2 0.0001
869 INJECTION SITE WARMTH 2 0.0001
870 INTENTIONAL DRUG MISUSE 2 0.0001
871 WITHDRAWAL SYNDROME 4 0.0001
872 DRUG EFFECT DECREASED 5 0.0001
873 PRODUCT USE IN UNAPPROVED INDICATION 23 0.0001
874 DISTURBANCE IN ATTENTION 5 0.0001
875 UNEVALUABLE EVENT 7 0.0001
876 INJECTION SITE SWELLING 7 0.0001
877 ANAPHYLACTIC REACTION 5 0.0001
878 ANGIOEDEMA 4 0.0001
879 RASH MACULO-PAPULAR 2 0.0001
880 HEPATOTOXICITY 2 0.0001
881 HYPOTENSION 18 0.0001
882 INJECTION SITE PRURITUS 6 0.0001
883 DEVICE ISSUE 8 0.0001
884 TYPE 2 DIABETES MELLITUS 3 0.0001
885 THERAPY NON-RESPONDER 4 0.0001
886 PANCREATITIS ACUTE 2 0.0001
887 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
888 CHROMATURIA 2 0.0001
889 CEREBROVASCULAR ACCIDENT 15 0.0001
890 PRODUCT QUALITY ISSUE 12 0.0001
891 INJECTION SITE REACTION 6 0.0001
892 LETHARGY 5 0.0001
893 DELIRIUM 3 0.0001
894 DEVICE USE ERROR 3 0.0001
895 RENAL DISORDER 4 0.0001
896 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
897 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
898 INJURY 6 0.0001
899 DEATH 73 0.0001
900 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
901 COMPLETED SUICIDE 7 0.0001
902 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
903 DEPRESSION 19 0.0001
904 DRUG INEFFECTIVE 110 0.0001
905 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
906 DIABETIC KETOACIDOSIS 2 0.0001
907 DRUG INTOLERANCE 8 0.0001
908 LOCALISED INFECTION 2 0.0001
909 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
910 HYPERGLYCAEMIA 3 0.0001
911 PRESYNCOPE 2 0.0001
912 AGITATION 6 0.0001
913 ABASIA 2 0.0001
914 PYREXIA 28 0.0001
915 NEUTROPENIA 11 0.0001
916 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
917 ACNE 6 0.0001
918 GASTRIC CANCER 2 0.0001
919 CARDIOVASCULAR DISORDER 2 0.0001
920 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
921 NERVOUSNESS 4 0.0001
922 MUCOSAL INFLAMMATION 2 0.0001
923 APPLICATION SITE ERYTHEMA 2 0.0001
924 ADVERSE EVENT 7 0.0001
925 INJECTION SITE HAEMORRHAGE 6 0.0001
926 JAUNDICE 2 0.0001
927 FREQUENT BOWEL MOVEMENTS 2 0.0001
928 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
929 PALLOR 2 0.0001
930 LUNG NEOPLASM MALIGNANT 3 0.0001
931 RESPIRATORY ARREST 2 0.0001
932 ABNORMAL DREAMS 2 0.0001
933 HOSPITALISATION 11 0.0001
934 PANCYTOPENIA 4 0.0001
935 THROMBOCYTOPENIA 8 0.0001
936 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
937 PANCREATIC CARCINOMA 2 0.0001
938 VAGINAL HAEMORRHAGE 3 0.0001
939 MENTAL DISORDER 3 0.0001
940 LIVER FUNCTION TEST ABNORMAL 2 0.0001
941 PRODUCT STORAGE ERROR 6 0.0001
942 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
943 SURGERY 4 0.0001
944 BLADDER CANCER 4 0.0001
945 LABORATORY TEST ABNORMAL 2 0.0001
946 HEPATIC FAILURE 2 0.0001
947 EMOTIONAL DISTRESS 8 0.0001
948 SKIN IRRITATION 3 0.0001
949 EPILEPSY 2 0.0001
950 INJECTION SITE RASH 2 0.0001
951 BLOOD CHOLESTEROL INCREASED 3 0.0001
952 NERVOUS SYSTEM DISORDER 2 0.0001
953 BLOOD GLUCOSE INCREASED 12 0.0001
954 MOOD SWINGS 2 0.0001
955 METABOLIC ACIDOSIS 2 0.0001
956 HYPOGLYCAEMIA 3 0.0001
957 SYNCOPE 6 0.0001
958 ANGER 2 0.0001
959 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
960 NEOPLASM PROGRESSION 2 0.0001
961 HAEMORRHAGE 6 0.0001
962 HYPERKALAEMIA 2 0.0001
963 PRODUCT ADHESION ISSUE 2 0.0001
964 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
965 SKIN BURNING SENSATION 4 0.0001
966 MYELOSUPPRESSION 2 0.0001
967 OEDEMA 3 0.0001
968 DRUG EFFECT INCOMPLETE 2 0.0001
969 PANIC ATTACK 2 0.0001
970 MEDICATION ERROR 3 0.0001
971 CONVULSION 3 0.0001
972 DISEASE PROGRESSION 6 0.0001
973 WHEEZING 3 0.0001
974 IRRITABILITY 3 0.0000
975 CARDIAC FAILURE CONGESTIVE 4 0.0000
976 THERAPEUTIC RESPONSE DECREASED 3 0.0000
977 SUICIDE ATTEMPT 3 0.0000
978 ILL-DEFINED DISORDER 3 0.0000
979 CARDIAC ARREST 4 0.0000
980 RHABDOMYOLYSIS 2 0.0000
981 OVERDOSE 10 0.0000
982 SEPTIC SHOCK 2 0.0000
983 COMA 2 0.0000
984 RENAL CANCER 2 0.0000
985 MULTIPLE SCLEROSIS 2 0.0000
986 PANCREATITIS 2 0.0000
987 SUICIDAL IDEATION 3 0.0000
988 DEVICE DIFFICULT TO USE 2 0.0000
989 NO ADVERSE EVENT 5 0.0000
990 TOXICITY TO VARIOUS AGENTS 4 0.0000